Literature DB >> 15298146

Prognostic factors in prostate cancer.

Jeffrey S Ross1, Timothy A Jennings, Tipu Nazeer, Christine E Sheehan, Hugh A G Fisher, Ronald A Kauffman, Shagul Anwar, Bhaskar V S Kallakury.   

Abstract

The ability of traditional and newer molecular-based prognostic factors to predict the outcome of prostate cancer is of considerable interest to urologists, pathologists, and patients. In this review, a series of traditional and newer molecular-based prognostic factors are considered, including those that have achieved widespread use, newer tests that are beginning to be used in clinical practice, and emerging molecular markers that have yet to be widely validated in the published literature or clinical trials.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15298146     DOI： 10.1309/PW69K48RRFJLXKBD

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


  8 in total

Review 1.  Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era.

Authors:  Håvard E Danielsen; Manohar Pradhan; Marco Novelli
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

2.  A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling.

Authors:  Bilal Bin Hafeez; Imtiaz Ahmad Siddiqui; Mohammad Asim; Arshi Malik; Farrukh Afaq; Vaqar Mustafa Adhami; Mohammad Saleem; Maria Din; Hasan Mukhtar
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

3.  Delphinidin, a dietary anthocyanidin in pigmented fruits and vegetables: a new weapon to blunt prostate cancer growth.

Authors:  Bilal Bin Hafeez; Mohammad Asim; Imtiaz Ahmad Siddiqui; Vaqar Mustafa Adhami; Imtiyaz Murtaza; Hasan Mukhtar
Journal:  Cell Cycle       Date:  2008-11-09       Impact factor: 4.534

4.  Alpha-tomatine induces apoptosis and inhibits nuclear factor-kappa B activation on human prostatic adenocarcinoma PC-3 cells.

Authors:  Sui-Ting Lee; Pooi-Fong Wong; Shiau-Chuen Cheah; Mohd Rais Mustafa
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

5.  Prognostic relevance of Tiam1 protein expression in prostate carcinomas.

Authors:  R Engers; M Mueller; A Walter; J G Collard; R Willers; H E Gabbert
Journal:  Br J Cancer       Date:  2006-09-26       Impact factor: 7.640

6.  Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse.

Authors:  J Domingo-Domenech; B Mellado; B Ferrer; D Truan; J Codony-Servat; S Sauleda; J Alcover; E Campo; P Gascon; A Rovira; J S Ross; P L Fernández; J Albanell
Journal:  Br J Cancer       Date:  2005-11-28       Impact factor: 7.640

7.  Identification of Morphologic Criteria Associated with Biochemical Recurrence in Intraductal Carcinoma of the Prostate.

Authors:  Mame-Kany Diop; Roula Albadine; André Kougioumoutzakis; Nathalie Delvoye; Hélène Hovington; Alain Bergeron; Yves Fradet; Fred Saad; Dominique Trudel
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

8.  Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy.

Authors:  Mayen T Grageda; Bonnie Choy; Gladell P Paner; Jeffrey S So
Journal:  Asian J Androl       Date:  2021 Sep-Oct       Impact factor: 3.285
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.